Compare stocks

DocCheck AG, founded in 1990 and headquartered in Cologne, Germany, provides marketing, customer relationship management, and e-commerce services tailored for the European healthcare sector. The company operates the DocCheck portal, a platform facilitating information exchange among healthcare professionals, and offers services such as online advertising, market research, and communication strategy development for healthcare and business-to-business sectors. Additionally, DocCheck AG invests in healthcare startups through its venture capital arm, DocCheck Guano AG. The company's subsidiaries include antwerpes AG, which develops integrated communication concepts for the healthcare sector, and DocCheck Shop GmbH, a leading e-commerce platform for medical and practice supplies in Europe.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.